ETFs
I
IVVD
Invivyd
1.365
-0.015-1.09%Opening10:57 04/29 EDT
OPEN/PREV CLOSE1.500/1.470
TODAY RANGE1.430-1.510
VOL288.68K
MARKET CAP405.82M
52 WEEK RANGE0.4830-3.070
AVG VOL (3M)2.73M
% TURNOVER0.10%
TURNOVER--
P/E (TTM)-4.7080
% RANGE5.44%
EPS(TTM)-0.3048
P/E(FORWARD)-4.3485
P/B1.675
BVPS0.8566
DIVIDEND--
P/S7.57
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP344.51M
SHARES OUTSTANDING282.80M
NEXT EARNINGS05/13-05/18
FREE FLOAT240.08M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·04/20 11:28
Invivyd annouces Chairman Elia to speak at POLITICO Health Care Summit
Reuters·04/20 11:01
INVIVYD ANNOUNCES CHAIRMAN MARC ELIA TO SPEAK AT POLITICO HEALTH CARE SUMMIT
Seeking Alpha·04/10 19:15
Invivyd: Why The Trial Upsizing Isn't The Green Light Bulls Think It Is
Seeking Alpha·04/09 17:23
Invivyd rises after update from late-stage trial for COVID therapy
Benzinga·04/09 17:05
12 Health Care Stocks Moving In Thursday's Intraday Session
TipRanks·04/09 16:02
Midday Fly By: Ares to acquire Whitestone REIT, Disney to make ‘sizable’ layoffs
Benzinga·04/09 14:54
BlackBerry Posts Upbeat Q4 Results, Joins Constellation Brands, Marvell Technology And Other Big Stocks Moving Higher On Thursday
Benzinga·04/09 14:07
Invivyd Stock Surges As FDA Alignment Boosts COVID-19 Program
TipRanks·04/09 13:34
Invivyd provides update on Phase 3 DECLARATION study of VYD2311
TipRanks·04/09 13:33
Invivyd announces discovery, advancement of measles antibody candidate VMS063
TipRanks·04/09 11:31
Invivyd Advances COVID-19 Program and Launches Measles Antibody
Same Industry
Name/Symbol
Change%
Price